Annual Operating Expenses
$38.67 M
+$13.56 M+54.01%
31 December 2023
Summary:
Soleno Therapeutics annual total operating expenses is currently $38.67 million, with the most recent change of +$13.56 million (+54.01%) on 31 December 2023. During the last 3 years, it has risen by +$6.72 million (+21.04%). SLNO annual operating expenses is now at all-time high.SLNO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$79.33 M
+$56.10 M+241.50%
30 September 2024
Summary:
Soleno Therapeutics quarterly total operating expenses is currently $79.33 million, with the most recent change of +$56.10 million (+241.50%) on 30 September 2024. Over the past year, it has increased by +$69.97 million (+747.51%). SLNO quarterly operating expenses is now at all-time high.SLNO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLNO Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +54.0% | +747.5% |
| 3 y3 years | +21.0% | +925.7% |
| 5 y5 years | +181.6% | +1199.5% |
SLNO Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +54.0% | at high | +1199.9% |
| 5 y | 5 years | at high | +181.6% | at high | +1199.9% |
| alltime | all time | at high | +975.0% | at high | >+9999.0% |
Soleno Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $79.33 M(+241.5%) |
| June 2024 | - | $23.23 M(+0.7%) |
| Mar 2024 | - | $23.07 M(+79.9%) |
| Dec 2023 | $38.67 M(+54.0%) | $12.83 M(+37.0%) |
| Sept 2023 | - | $9.36 M(+12.6%) |
| June 2023 | - | $8.31 M(+1.7%) |
| Mar 2023 | - | $8.17 M(+31.5%) |
| Dec 2022 | $25.11 M(-22.2%) | $6.21 M(+1.8%) |
| Sept 2022 | - | $6.10 M(-1.0%) |
| June 2022 | - | $6.16 M(-7.1%) |
| Mar 2022 | - | $6.63 M(+4.8%) |
| Dec 2021 | $32.26 M(+1.0%) | $6.33 M(-18.2%) |
| Sept 2021 | - | $7.74 M(-3.9%) |
| June 2021 | - | $8.05 M(-20.6%) |
| Mar 2021 | - | $10.14 M(+29.8%) |
| Dec 2020 | $31.95 M(+37.7%) | $7.82 M(+10.4%) |
| Sept 2020 | - | $7.08 M(-15.2%) |
| June 2020 | - | $8.35 M(-4.0%) |
| Mar 2020 | - | $8.70 M(+26.4%) |
| Dec 2019 | $23.20 M(+68.9%) | $6.88 M(+12.7%) |
| Sept 2019 | - | $6.11 M(+12.2%) |
| June 2019 | - | $5.44 M(+14.0%) |
| Mar 2019 | - | $4.77 M(+34.2%) |
| Dec 2018 | $13.73 M | $3.56 M(-2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $3.65 M(+4.9%) |
| June 2018 | - | $3.48 M(+14.2%) |
| Mar 2018 | - | $3.05 M(+12.6%) |
| Dec 2017 | $9.68 M(+16.3%) | $2.71 M(+2.9%) |
| Sept 2017 | - | $2.63 M(-11.4%) |
| June 2017 | - | $2.97 M(+116.2%) |
| Mar 2017 | - | $1.37 M(-25.1%) |
| Dec 2016 | $8.32 M(-31.7%) | $1.83 M(-6.9%) |
| Sept 2016 | - | $1.97 M(-12.4%) |
| June 2016 | - | $2.25 M(-47.1%) |
| Mar 2016 | - | $4.25 M(+21.7%) |
| Dec 2015 | $12.19 M(+136.3%) | $3.49 M(+8.5%) |
| Sept 2015 | - | $3.22 M(+3.2%) |
| June 2015 | - | $3.12 M(+28.4%) |
| Mar 2015 | - | $2.43 M(+31.7%) |
| Dec 2014 | $5.16 M(+34.1%) | $1.85 M(+39.5%) |
| Sept 2014 | - | $1.32 M(+1.2%) |
| June 2014 | - | $1.31 M(+91.1%) |
| Mar 2014 | - | $684.00 K(+22.2%) |
| Dec 2013 | $3.85 M(+6.9%) | $559.80 K(-43.6%) |
| Sept 2013 | - | $993.00 K(-15.6%) |
| June 2013 | - | $1.18 M(+5.1%) |
| Mar 2013 | - | $1.12 M |
| Dec 2012 | $3.60 M | - |
FAQ
- What is Soleno Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Soleno Therapeutics?
- What is Soleno Therapeutics annual operating expenses year-on-year change?
- What is Soleno Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly operating expenses year-on-year change?
What is Soleno Therapeutics annual total operating expenses?
The current annual operating expenses of SLNO is $38.67 M
What is the all time high annual operating expenses for Soleno Therapeutics?
Soleno Therapeutics all-time high annual total operating expenses is $38.67 M
What is Soleno Therapeutics annual operating expenses year-on-year change?
Over the past year, SLNO annual total operating expenses has changed by +$13.56 M (+54.01%)
What is Soleno Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of SLNO is $79.33 M
What is the all time high quarterly operating expenses for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly total operating expenses is $79.33 M
What is Soleno Therapeutics quarterly operating expenses year-on-year change?
Over the past year, SLNO quarterly total operating expenses has changed by +$69.97 M (+747.51%)